Congestive Heart Failure - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

文章摘要

Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure
Clinical applications of machine learning in the diagnosis, classification, and prediction of heart failure
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced
Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure
The spectrum of heart failure: value of left ventricular ejection fraction and its moving trajectories
Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study
Nocturnal thoracic volume overload and post-discharge outcomes in patients hospitalized for acute heart failure
The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure
Dapagliflozin for treating chronic heart failure with reduced ejection fraction

|<<... 6 7 8 9 10 11 12 ...>>|

Review Article

2017 Nov;5(11):763-771.

JOURNAL：JACC Heart Fail.

Article Link

Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions

Hsu JJ, Ziaeian B, Fonarow GC.

3003

Keywords: HFbEF; HFmrEF; HFpEF; epidemiology; heart failure with borderline ejection fraction; heart failure with mid-range ejection fraction; heart failure with preserved ejection fraction; outcomes

FULL TEXT PDF